Bio-implants Market

CHAPTER 1 INTRODUCTION

1.1 Report Description
1.2 Reason for doing the study
1.3 Key Benefits
1.4 Key Market Segments
1.5 Key Audiences
1.6 Research Methodology

1.6.1 Secondary Research
1.6.2 Primary Research
1.6.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond: what to expect by 2025

2.2.1 Moderate growth scenario, (2020-2025)
2.2.2 Rapid growth scenario, (2020-2025)
2.2.3 Diminishing growth scenario, (2020-2025)

CHAPTER 3 GLOBAL BIOIMPLANTS MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Key findings

3.2.1 Top Factors Impacting Global Bio implant Market
3.2.2 Top Winning Strategies in Global Bio implant Market
3.2.3 Top Investment Pockets of Global Bio implant Market

3.3 Nanosheet Biomaterials: Novel approach for wound healing
3.4 Transformation in Brain studies: 3D Brain-like tissues
3.5 Biomaterial used in bioimplants (Comparison)
3.6 Porter’s five forces analysis

3.6.1 Bargaining power of Suppliers
3.6.2 Bargaining power of buyers
3.6.3 Threats from substitute products
3.6.4 Threat from new entrants
3.6.5 Industry rivalry

3.7 Value Chain analysis
3.8 Government Regulations
3.9 Market share analysis,2013
3.10 Market Dynamics

3.10.1 Drivers

3.10.1.1 Technological advancement
3.10.1.2 Rising incidence of trauma injuries
3.10.1.3 Increasing government initiatives
3.10.1.4 Growing elderly population

3.10.2 Restraints

3.10.2.1 Instability of bio Implants
3.10.2.2 Corrosion of bio implant
3.10.2.3 Increasing Price Competition and deterioration of material quality

3.10.3 Opportunities

3.10.3.1 Novel bio implants
3.10.3.2 evolution in bio implants

CHAPTER 4 GLOBAL BIO IMPLANTS MARKET BY TYPES

4.1 Cardiovascular

4.1.1 Market size and forecast
4.1.2 Stents
4.1.3 Pacing Devices

4.1.3.1 Implantable Cardiac Defibrillators (ICD) applications

4.1.4 Others

4.1.4.1 Heart Valves
4.1.4.2 Catheters
4.1.4.3 Vascular Grafts
4.1.4.4 Guidewires
4.1.4.5 Wireless Sensors

4.2 Dental and Prosthetic Implants

4.2.1 Market size and forecast
4.2.2 Plate form dental implants
4.2.3 Root form dental implants

4.3 Orthopedic/Joint Reconstruction and Replacement bio implants

4.3.1 Market size and forecast
4.3.2 Orthobiologics
4.3.3 Trauma Implants
4.3.4 Sport Medicines
4.3.5 Joint Replacement Bio implants

4.3.5.1 Knee Replacement Bioimplants
4.3.5.2 Hip Replacement Bioimplants

4.3.6 Wound Healing
4.3.7 Market size and forecast
4.3.8 Fracture Fixation Devices

4.3.8.1 Sutures and Staples

4.4 Spinal Bio implants

4.4.1 Thoracolumber implants
4.4.2 Interverteberal spacers
4.4.3 Machined Allograft Spacers
4.4.4 Motion Preservation implants
4.4.5 Implantable spinal stimulators

4.5 Ophthalmology Bio implants

4.5.1 Market size and forecast
4.5.2 Glaucoma Implants
4.5.3 Intraocular Implants

4.6 Others

4.6.1 Tissue Engineering

4.6.1.1 Growth Factors
4.6.1.2 Stem Cell Therapy
4.6.1.3 Nanomaterials For Tissue Engineering
4.6.1.4 Nanoparticles
4.6.1.5 Nanoscaffolds

4.6.2 Neurological disorders
4.6.3 Market size and forecast

CHAPTER 5 GLOBAL BIO IMPLANTS MARKET BY GEOGRAPHY

5.1 North America

5.1.1 Key Market Trends
5.1.2 Competitive Scenario
5.1.3 Key Growth Factors and Opportunities
5.1.4 Market size and Forecast

5.2 Asia Pacific

5.2.1 Key Market Trends
5.2.2 Competitive Scenario
5.2.3 Key Growth Factors and Opportunities
5.2.4 Market size and Forecast

5.3 LAMEA

5.3.1 Key Market Trends
5.3.2 Key Growth Factors and Opportunities
5.3.3 Market size and Forecast

CHAPTER 6 EUROPEAN BIO IMPLANTS MARKET ANALYSIS

6.1 Market Dynamics

6.1.1 Drivers

6.1.1.1 High Prevalence of lifestyle diseases
6.1.1.2 lucrative medical tourism destination
6.1.1.3 Growing aging population

6.1.2 Restraints

6.1.2.1 Government Regulations
6.1.2.2 Increasing Price Competition

6.2 Key Market Trends

6.2.1 Market size and forecast

6.3 Government Regulations
6.4 Germany Bioimplants market, 2013-2020, $million
6.5 France Bioimplants market, 2013-2020, $million
6.6 The United Kingdom Bioimplants market, 2013-2020, $million
6.7 The Netherlands bio implants market, 2013-2020, $million
6.8 Bioimplants market in other European countries, 2013-2020, $million
6.9 Company analysis by region

6.9.1 Germany

6.9.1.1 Biotronik

6.9.1.1.1 COMPANY OVERVIEW
6.9.1.1.2 RECENT DEVELOPMENTS

6.9.1.2 B.Braun

6.9.1.2.1 COMPANY OVERVIEW

6.9.2 France

6.9.2.1 SBM (Science for Biomaterials)

6.9.2.1.1 COMPANY OVERVIEW

6.9.2.2 kasios

6.9.2.2.1 COMPANY OVERVIEW

6.9.3 UK

6.9.3.1 Smith & Nephew

6.9.3.1.1 COMPANY OVERVIEW
6.9.3.1.2 RECENT DEVELOPMENTS

6.9.3.2 Mediplus

6.9.3.2.1 COMPANY OVERVIEW

CHAPTER 7 COMPANY PROFILE

7.1 DENTSPLY International

7.1.1 Company Overview
7.1.2 Operating Segments
7.1.3 Business Performance
7.1.4 Strategic Move and Development
7.1.5 SWOT Analysis of DENTSPLY International

7.2 Wright Medical Group

7.2.1 Company Overview
7.2.2 Operating segments
7.2.3 Business Performance
7.2.4 Strategic Move and Development
7.2.5 SWOT Analysis of Wright Medical Group

7.3 Invibio Biomaterial Solutions

7.3.1 Company Overview
7.3.2 Operating Segments
7.3.3 Strategic move and development
7.3.4 SWOT Analysis of Invibio Biomaterial Solutions

7.4 BIOMET (Zimmer)

7.4.1 Company Overview
7.4.2 Operating Segments
7.4.3 Business Performance
7.4.4 Strategic move and Development
7.4.5 SWOT Analysis of BIOMET

7.5 Medtronic, Inc.

7.5.1 Company overview
7.5.2 Operating segments
7.5.3 Business performance
7.5.4 Strategic moves and developments
7.5.5 SWOT Analysis

7.6 Stryker Corporation

7.6.1 Company Overview
7.6.2 Operating segments
7.6.3 Business performance
7.6.4 Strategic moves and developments
7.6.5 SWOT Analysis

7.7 Smith & Nephews

7.7.1 Company Overview
7.7.2 Operating segments
7.7.3 Business Performance
7.7.4 Strategic move and development
7.7.5 SWOT Analysis of Smith and Nephew

7.8 DePuy Synthes

7.8.1 Company Overview
7.8.2 DePuy Synthes Operating segments
7.8.3 Business Performance
7.8.4 Strategic move and development
7.8.5 SWOT Analysis Of DePuy Synthes

7.9 Ethicon Inc.

7.9.1 Company Overview
7.9.2 Operating segments
7.9.3 Business Performance
7.9.4 Strategic Moves and Development
7.9.5 SWOT Analysis of Ethicon

7.10 KLS Martin

7.10.1 Company overview
7.10.2 Operating segments
7.10.3 Strategic move and development
7.10.4 SWOT Analysis of KLS Martin

LIST OF TABLES

TABLE 1 BIOMATERIAL COMPARISON WITH EXAMPLES
TABLE 2 BIOMATERIALS CHARACTERISTICS
TABLE 3 INCIDENT OF MECHANICAL TRAUMATIC INJURIES IN USA (2013)
TABLE 4 TRAUMA INJURY FACILITIES BY REGION
TABLE 5 TOP 10 COUNTRIES HEALTHCARE EXPENDITURE 2013
TABLE 6 POPULATION STATISTICS OF 2013, BY AGE AND SEX (THOUSANDS)
TABLE 7 ADVERSE REACTIONS REPORTED WITH DENTAL MATERIALS IN UK
TABLE 8 GLOBAL BIO IMPLANTS MARKET REVENUE BY APPLICATION, 2013-2020 ($MILLION)
TABLE 9 CARDIOVASCULAR IMPLANTS
TABLE 10 GLOBAL CARDIOVASCULAR BIO IMPLANT MARKET REVENUE BY TYPES, 2013-2020 ($MILLION)
TABLE 11 GLOBAL CARDIOVASCULAR BIO IMPLANT MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 12 GLOBAL CARDIOVASCULAR STENT BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 13 GLOBAL OTHER CARDIOVASCULAR BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 14 GLOBAL DENTAL BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 15 BIO IMPLANTS ORTHOPEDIC IMPLANTS
TABLE 16 MARKET PLAYERS IN ORTHOPEDIC IMPLANTS
TABLE 17 GLOBAL ORTHOPEDIC/JOINT RECONSTRUCTION AND REPLACEMENT BIO IMPLANTS BIO IMPLANTS MARKET REVENUE BY TYPES, 2013-2020 ($MILLION)
TABLE 18 GLOBAL ORTHOPEDIC/JOINT RECONSTRUCTION AND REPLACEMENT BIO IMPLANTS BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 19 BIO IMPLANTS USED IN WOUND DRESSINGS
TABLE 20 GLOBAL SPINAL BIO IMPLANTS MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 21 GLOBAL SPINAL BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 22 GLOBAL THORACOLUMBER IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 23 GLOBAL INTERVERTEBERAL SPACERS MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 24 GLOBAL MACHINED ALLOGRAFT SPACERS MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 25 GLOBAL MOTION PRESERVATION IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 26 GLOBAL IMPLANTABLE SPINAL STIMULATORS MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 27 BIO IMPLANTS/DEVICES USED IN OPHTHALMOLOGY
TABLE 28 GLOBAL OPHTHALMOLOGY BIO IMPLANTS MARKET REVENUE BY TYPE, 2013-2020 ($MILLION)
TABLE 29 GLOBAL OPHTHALMOLOGY BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 30 GLOBAL OPHTHALMOLOGY BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 31 GLOBAL OPHTHALMOLOGY BIO IMPLANTS MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 32 BIO IMPLANT APPLICABLE AT DIFFERENT LEVEL TISSUE ENGINEERING
TABLE 33 GLOBAL OTHERS APPLICATION MARKET REVENUE BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 34 NORTH AMERICA BIOIMPLANT MARKET REVENUE BY PRODUCT TYPES, 2013-2020 ($MILLION)
TABLE 35 ASIA-PACIFIC BIOIMPLANTS MARKET REVENUE BY PRODUCT TYPE, 2013-2020 ($MILLION)
TABLE 36 LAMEA BIOIMPLANTS MARKET REVENUE BY PRODUCT TYPES, 2013-2020 ($MILLION)
TABLE 37 POPULATION STATISTICS OF 2013, BY AGE AND SEX (THOUSANDS)
TABLE 38 EUROPEAN BIOIMPLANTS MARKET REVENUE BY PRODUCT TYPES, 2013-2020 ($MILLION)
TABLE 39 GERMANY BIO IMPLANT MARKET BY APPLICATION, 2013-2020, $MILLION
TABLE 40 FRANCE BIO IMPLANT MARKET BY APPLICATION, 2013-2020, $MILLION
TABLE 41 THE UNITED KINGDOM BIO IMPLANT MARKET BY APPLICATION, 2013-2020, $MILLION
TABLE 42 THE NETHERLANDS BIO IMPLANT MARKET BY APPLICATION, 2013-2020, $MILLION
TABLE 43 OTHER EUROPEAN COUNTRIES BIO IMPLANT MARKET BY APPLICATION, 2013-2020, $MILLION
TABLE 44 DENTSPLY SNAPSHOT
TABLE 45 DENTSPLY INTERNATIONAL OPERATING SEGMENTS
TABLE 46 REVENUE BY BUSINESS SEGMENT, 2013
TABLE 47 SWOT ANALYSIS OF DENTSPLY INTERNATIONAL
TABLE 48 WRIGHT MEDICAL GROUP SNAPSHOT
TABLE 49 WRIGHT MEDICAL GROUP OPERATING SEGMENTS
TABLE 50 REVENUE BY BUSINESS SEGMENT (2013)
TABLE 51 REVENUE BY GEOGRAPHY (2013)
TABLE 52 SWOT ANALYSIS OF WRIGHT MEDICAL GROUP
TABLE 53 INVIBIO BIOMATERIAL SOLUTIONS SNAPSHOT
TABLE 54 INVIBIO BIOMATERIAL SOLUTIONS OPERATING SEGMENTS
TABLE 55 SWOT ANALYSIS OF INVIBIO BIOMATERIAL SOLUTIONS
TABLE 56 BIOMET (ZIMMER) SNAPSHOT
TABLE 57 BIOMET (ZIMMER) OPERATING SEGMENTS
TABLE 58 SWOT ANALYSIS OF BIOMET (ZIMMER)
TABLE 59 MEDTRONIC SNAPSHOT
TABLE 60 MEDTRONIC OPERATING SEGMENTS
TABLE 61 STRYKER CORPORATION SNAPSHOT
TABLE 62 SMITH & NEPHEW SNAPSHOT
TABLE 63 SMITH & NEPHEW OPERATING SEGEMENTS
TABLE 64 DEPUY SYNTHES SNAPSHOT
TABLE 65 DEPUY SYNTHES OPERATING SYSTEM
TABLE 66 ETHICON SNAPSHOT
TABLE 67 ETHICON OPERATING SEGMENTS
TABLE 68 KLS MARTIN SNAPSHOT
TABLE 69 KLS MARTIN OPERATING SEGMENTS

LIST OF FIGURES

FIG. 1 IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO (2020-2025)
FIG. 2 IMPACT ANALYSIS OF RAPID GROWTH SCENARIO (2020-2025)
FIG. 3 IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO (2020-2025)
FIG. 4 TOP FACTORS IMPACTING GLOBAL BIO IMPLANTS MARKET, 2013-2020
FIG. 5 TOP WINNING STRATEGIES IN GLOBAL BIO IMPLANTS MARKET 2011-2014
FIG. 6 TOP WINNING STRATEGIES IN GLOBAL BIO IMPLANTS MARKET, 2011-2014
FIG. 7 TOP INVESTMENT POCKETS OF GLOBAL BIO IMPLANTS MARKET
FIG. 8 PORTER’S FIVE FORCE MODEL OF BIO IMPLANTS MARKET
FIG. 9 VALUE CHAIN ANALYSIS OF BIO IMPLANTS MARKET
FIG. 10 AVERAGE APPROVAL TIME FOR DIFFERENT CLASSES OF MEDICAL DEVICE IN LEADING MARKETS IN 2013
FIG. 11 MARKET SHARE ANALYSIS OF BIO IMPLANTS MARKET 2013
FIG. 12 REVENUE BY BUSINESS SEGMENT, 2013
FIG. 13 REVENUE BY GEOGRAPHY,2013
FIG. 14 REVENUE BY GEOGRAPHY(2013)
FIG. 15 REVENUE BY BUSINESS SEGMENTS (2013)
FIG. 16 SWOT ANALYSIS OF MEDTRONIC
FIG. 17 REVENUE BY GEOGRAPHY(2013)
FIG. 18 REVENUE BY BUSINESS SEGMENTS (2013)
FIG. 19 SWOT ANALYSIS OF STRYKER CORPORATION
FIG. 20 SMITH & NEPHEWS REVENUE BY BUSINESS SEGMENTS,2013
FIG. 21 SMITH & NEPHEWS REVENUE BY GEOGRAPHY, 2013
FIG. 22 SWOT ANALYSIS OF SMITH AND NEPHEW
FIG. 23 SWOT ANALYSIS OF DEPUY SYNTHES
FIG. 24 REVENUE BY GEOGRAPHY (2013)
FIG. 25 REVENUE BY BUSINESS SEGMENT (2013)
FIG. 26 SWOT ANALYSIS OF ETHICON
FIG. 27 SWOT ANALYSIS OF KLS MARTIN